Total planned funding: $533,005,547
Clear active filters
Namibia
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Namibia | $533,005,547 |
Organizational Types
NGO | $146,673,720 |
Private Contractor | $115,209,165 |
Host Country Government Agency | $66,721,771 |
Own Agency | $65,534,836 |
Unknown | $60,029,398 |
University | $53,065,201 |
Parastatal | $13,245,617 |
Other USG Agency | $6,769,875 |
Implementing Agency | $2,420,125 |
Multi-lateral Agency | $1,830,195 |
FBO | $1,505,644 |
Program Areas
Treatment | $156,731,698 |
Prevention | $114,122,291 |
Care | $101,968,837 |
Governance and Systems | $79,975,281 |
Management and Operations | $40,151,996 |
Testing | $40,055,444 |
Budget Codes
HTXS: Treatment: Adult Treatment | $131,991,281 |
HKID: Care: Orphans and Vulnerable Children | $43,783,898 |
HVMS: Management and Operations | $40,151,996 |
HVCT: Testing: HIV Testing and Counseling | $40,055,444 |
HVOP: Sexual Prevention: Other Sexual Prevention | $36,805,907 |
OHSS: Health Systems Strengthening | $35,314,163 |
HVSI: Strategic Information | $34,357,553 |
HBHC: Care: Adult Care and Support | $31,488,951 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $27,458,941 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $23,157,787 |
HVTB: Care: TB/HIV | $19,946,172 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $18,073,756 |
HTXD: Treatment: ARV Drugs | $14,547,396 |
HLAB: Laboratory Infrastructure | $10,303,565 |
PDTX: Treatment: Pediatric Treatment | $10,193,021 |
PDCS: Care: Pediatric Care and Support | $6,749,816 |
HMBL: Biomedical Prevention: Blood Safety | $5,890,437 |
HMIN: Biomedical Prevention: Injection Safety | $2,735,463 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Potentia Namibia:
$66,886,765
Countries/Regions
University of Washington:
$44,386,474
Countries/Regions
Not Available:
$43,126,770
Countries/Regions
Project HOPE:
$29,449,185
Countries/Regions